Back to All Events

Boston International Symposium


Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success

If you registered for the 2022 Boston International Symposium in-person or virtually, you will have access to the entire virtual program until 30 December 2022.

After 30 December, the program sessions will be available on ISSCR.digital On-Demand.

 

Program


Keynote Speaker

Speakers & Topics

Preclinical Strategies

Sponsored by : Astellas Institute for Regenerative Medicine

April Craft, PhD, Boston Children’s Hospital, USA
Douglas A. Melton, PhD, Vertex Pharmaceuticals and Harvard University, USA
Su-Chun Zhang, MD, PhD, Duke-NUS Medical University, Singapore and University of Wisconsin-Madison, USA
Kareen Coulombe, PhD, Brown University, USA

Selecting Your Cell Line: Derivation and Characterization

Sponsored by: ElevateBio

Tenneille Ludwig, PhD, WiCell, USA
Nissim Benvenisty, PhD, Hebrew University, Israel
Jennifer Dashnau, PhD, Century Therapeutics, USA

What's In Your Product

Deborah Hursh, PhD, FDA Center for Biologics Evaluation and Research, USA
Bahram (Bob) Valamehr
, PhD, MBA, FATE Therapeutics, USA
Angela Keightley, PhD, BlueRock Therapeutics, Canada

New Technologies/Where Are We Going?

Howard Kim, PhD, The New York Stem Cell Foundation (NYSCF), USA
Kapil Bharti, PhD, NIH, USA
Peter Zandstra, PhD, University of British Columbia, Canada
Kévin Alessandri, PhD, TreeFrog Therapeutics, France
Kiera Dwyer, Brown University, USA

Immunology for Cell Therapies

Ran Jing, PhD, Harvard Medical School, USA
Sonja Schrepfer, MD, PhD, Sana Biotechnology and University of California, San Francisco, USA
Shin Kaneko, MD, PhD, CiRA, Kyoto University, Japan

Balancing Science and Regulatory Requirements in Emerging Fields

Sponsored by: Cellino Biotech

Anthony Oro, MD, PhD, Stanford University, USA
Gesine Paul-Visse, MD, Lund University, Sweden
Melissa Carpenter, PhD, ElevateBio, USA

How to Accelerate with Accelerated Designations

Jane Lebkowski, PhD, Regenerative Patch Technologies, USA
Masayo Takahashi, MD, Vision Care, Inc., Japan
Jacqueline Barry, PhD, Cell & Gene Therapy Catapult, UK

Delivering Your Cell Product: Strategies for Success

Sponsored by: Vertex Pharmaceuticals

Timothy Kamp, MD, PhD, University of Wisconsin, USA
Cory R. Nicholas, PhD,
Neurona Therapeutics, USA

 

This program is made possible with support from:

Previous
Previous
October 4

ON-DEMAND: Madison International Symposium

Next
Next
January 17

ISSCR Digital: Standards for Human Stem Cell Use in Research